↓ Skip to main content

Prophylactic methylxanthine for prevention of apnoea in preterm infants

Overview of attention for article published in Cochrane database of systematic reviews, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

blogs
1 blog
wikipedia
1 Wikipedia page

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
104 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prophylactic methylxanthine for prevention of apnoea in preterm infants
Published in
Cochrane database of systematic reviews, December 2010
DOI 10.1002/14651858.cd000432.pub2
Pubmed ID
Authors

David J Henderson-Smart, Antonio G De Paoli

Abstract

Recurrent apnoea is common in preterm infants. These episodes can lead to hypoxaemia and bradycardia, which may be severe enough to require the use of positive pressure ventilation. In infants with apnoea, methylxanthine treatment has been used successfully to prevent further episodes. It is possible that prophylactic therapy given to all very preterm infants soon after birth might prevent apnoea and the need for additional ventilator support.

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Argentina 1 <1%
Netherlands 1 <1%
Unknown 101 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Unspecified 13 13%
Student > Ph. D. Student 11 11%
Student > Bachelor 11 11%
Other 11 11%
Other 38 37%
Readers by discipline Count As %
Medicine and Dentistry 56 54%
Unspecified 15 14%
Nursing and Health Professions 9 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 14 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2015.
All research outputs
#1,100,270
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#3,162
of 8,923 outputs
Outputs of similar age
#14,501
of 144,719 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 100 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.